Ismail M A, Nelson K E, Larson P, Moses V K
Department of Medicine, University of Illinois College of Medicine, Chicago.
J Reprod Med. 1990 Feb;35(2):168-74.
A double-blind study was done to test the efficacy of cefoxitin in the prevention of post-cesarean-section infection. The antibiotic was given in three 2-g doses; the initial dose was given immediately after the cord was clamped, and subsequent doses were given four and eight hours later. Cefoxitin prophylaxis significantly reduced morbidity serious enough to require therapeutic antibiotics or to prolong the hospital stay and led to an overall reduction in the anaerobic microbial flora of the endocervix. However, the antibiotic was selective for the overgrowth of enterococci, which were present in nearly half the postoperative cultures of patients who had received the drug. Enterococcal sepsis occurred in one patient, and three other patients had significant bacteriuria and/or urinary tract infections from enterococci. No cefoxitin-resistant strains of Enterobacteriaceae, among species normally sensitive to the drug, were isolated from the stool samples after prophylaxis. The risk of enterococcal colonization and superinfection must be weighted against the benefits of reduction of the infection risk when deciding upon routine antibiotic prophylaxis for cesarean section.
进行了一项双盲研究,以测试头孢西丁预防剖宫产术后感染的疗效。抗生素分三次给予,每次2克;初始剂量在脐带结扎后立即给予,随后的剂量在4小时和8小时后给予。头孢西丁预防措施显著降低了严重到需要使用治疗性抗生素或延长住院时间的发病率,并导致宫颈内厌氧微生物菌群总体减少。然而,这种抗生素对肠球菌过度生长具有选择性,在接受该药物治疗的患者术后培养物中,近一半存在肠球菌。一名患者发生了肠球菌败血症,另外三名患者出现了明显的菌尿和/或来自肠球菌的尿路感染。在预防后,从粪便样本中未分离出对该药物通常敏感的肠杆菌科中耐头孢西丁的菌株。在决定剖宫产常规抗生素预防措施时,必须权衡肠球菌定植和二重感染的风险与降低感染风险的益处。